COVID-19 pandemic. What have we learned?

Area of Science:

• Pediatric Pathology
• Infectious Diseases
• Public Health

Background:

• COVID-19 pandemic declared March 2020, impacting pediatric populations.
• Children exhibit infection rates similar to adults, but typically with milder symptoms.
• Low rates of hospitalization, intensive care, and mortality observed in pediatric COVID-19 cases, especially in healthy children.

Purpose of the Study:

• To review the role of SARS-CoV-2 in pediatric pathology.
• To summarize clinical manifestations and outcomes in children.
• To discuss the impact of the pandemic on pediatric health and education.

Main Methods:

• Literature review and analysis of available data on pediatric COVID-19.
• Examination of clinical diagnoses, including common infections and multisystemic inflammatory syndrome in children (MIS-C).
• Assessment of vertical transmission, neonatal infections, and treatment approaches like remdesivir.

Main Results:

• Most pediatric COVID-19 cases are mild or asymptomatic.
• Common diagnoses include respiratory and gastrointestinal infections; MIS-C is a serious complication.
• Vertical transmission is low (<1%), with mild neonatal infections; breastfeeding and cohabitation are safe.
• Collateral damage includes affected mental health and access to care.
• Schooling did not increase infections; schools are vital for health and education.

Conclusions:

• Pediatric COVID-19 is generally mild, but MIS-C requires attention.
• Primary care and schools play crucial roles in managing pediatric health during the pandemic.
• Maintaining safety measures in schools is essential for children's overall well-being and development.